Cambium Networks Announces Nasdaq Hearings Panel Has Granted Continued Listing

Cambium Networks (NASDAQ:CMBM) announced the Nasdaq Hearings Panel granted continued listing on December 3, 2025, subject to conditions.

Rhea-AI Summary

Cambium Networks (NASDAQ:CMBM) announced the Nasdaq Hearings Panel granted continued listing on December 3, 2025, subject to conditions. The company must demonstrate compliance with Listing Rule 5450(a)(1) (minimum $1.00 bid) and Listing Rule 5250(c)(1) (timely SEC filings), and show compliance with the Filing Rule on or before April 16, 2026.

The Decision Letter noted the company had a closing bid ≥$1.00 for ten consecutive trading sessions as of the letter date. Nasdaq will retain jurisdiction through April 8, 2026 to monitor minimum-bid compliance and may impose a one-year discretionary monitor if compliance is maintained.

Positive

• Nasdaq Hearings Panel granted continued listing on Dec 3, 2025
• Closing bid price ≥ $1.00 for ten consecutive sessions as of Decision Letter

Negative

• Multiple delinquent SEC filings remain outstanding through Sep 30, 2025
• Must demonstrate Filing Rule compliance by Apr 16, 2026 or risk delisting
• Nasdaq will monitor minimum-bid compliance until Apr 8, 2026

Argus Dec 5 session

+9.83% close to close Open Argus

Details

News Market Reaction – CMBM

On Dec 5, the day this news came out, CMBM closed 9.83% above the previous close.

Data tracked by StockTitan Argus for the Dec 5 session.

Key Figures

Share price: $1.73 Trading volume: 7,464,189 shares 20-day average volume: 4,027,637 shares +5 more

Share price

$1.73

Pre-news price on publication date

Trading volume

7,464,189 shares

Volume on publication date

20-day average volume

4,027,637 shares

Pre-news 20-day average volume

52-week high

$6.80

Pre-news 52-week high

52-week low

$0.2314

Pre-news 52-week low

Market cap

$47,449,597

Pre-news market capitalization

Minimum bid price

$1.00

Required by Nasdaq Listing Rule 5450(a)(1)

Compliance deadline

April 16, 2026

Deadline to regain compliance with Filing Rule

Historical Context

5 past events · Latest: Dec 01

5 events

1. Dec 01

   Nasdaq deficiency notice

   24h Move

   -8.5%

   Additional Nasdaq letter for delinquent Q3 10-Q and prior filings.

2. Nov 18

   Financial update

   24h Move

   -2.6%

   Q3 shipment and order update with new product rollout details.

3. Oct 29

   Product integration

   24h Move

   +377.4%

   Integration of Cambium ONE Network with Starlink for enterprise service.

4. Oct 16

   Nasdaq delisting risk

   24h Move

   -6.1%

   Nasdaq Staff Determination Letter citing bid-price and filing failures.

5. Oct 14

   Product launch

   24h Move

   +3.9%

   Launch of new low-cost, high-performance ePMP subscriber modules.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

nasdaq listing rule 5450(a)(1), nasdaq listing rule 5250(c)(1), minimum bid price rule, filing rule, +3 more

7 terms

nasdaq listing rule 5450(a)(1) regulatory

"compliance with the Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Rule")"

Nasdaq Listing Rule 5450(a)(1) is a continued-listing standard that sets a minimum share price companies must maintain to remain listed on the Nasdaq market—commonly a $1.00 per-share threshold. Investors care because falling below that floor can trigger a compliance review and possible delisting, which is like failing a minimum grade and losing access to the public market; delisting can reduce liquidity, visibility and the ability to raise capital.

nasdaq listing rule 5250(c)(1) regulatory

"and the Nasdaq Listing Rule 5250(c)(1) (the "Filing Rule"), and certain other conditions"

Nasdaq Listing Rule 5250(c)(1) requires companies listed on the Nasdaq stock exchange to promptly notify the exchange if their stock price falls below a certain minimum level, known as the "initial listing standards." This rule helps ensure that investors are aware of significant declines in a company's stock value, which could signal financial trouble or increased risk. Essentially, it helps maintain transparency and protect investors by keeping them informed about important changes in a company's stock performance.

minimum bid price rule regulatory

"compliance with the Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Rule")"

A minimum bid price rule is a stock market requirement that a listed company's share must trade above a set minimum price over a specified period to remain listed on an exchange. It matters to investors because falling below that threshold can trigger warnings, potential delisting, and reduced liquidity—similar to a student needing a passing grade to stay enrolled—making the shares harder to buy, sell, or value accurately.

filing rule regulatory

"and the Nasdaq Listing Rule 5250(c)(1) (the "Filing Rule"), and certain other conditions"

A filing rule is a regulatory requirement that determines what information a company must submit to a regulator or exchange and when it must be submitted. Think of it as a checklist and deadline that keeps companies honest and investors informed, like a routine inspection report for a business; missing or late filings can signal risk, delay access to markets, or trigger penalties, so investors watch them as a measure of transparency and compliance.

form 10-k regulatory

"file its Annual Report on Form 10-K for the year ended December 31, 2024"

A Form 10-K is a comprehensive report that publicly traded companies are required to file annually with regulators. It provides a detailed overview of a company's financial health, operations, and risks, similar to a detailed health report. Investors use this information to assess the company's performance and make informed decisions about buying or selling its stock.

form 10-q regulatory

"its Quarterly Reports on Form 10-K for the periods ended March 31, 2025 and June 30, 2025."

A Form 10-Q is a detailed report that publicly traded companies are required to file with regulators three times a year, providing an update on their financial health and business activities. It is important for investors because it offers timely insights into a company's performance, helping them make informed decisions about buying or selling stocks. Think of it as a regular check-up report that shows how well a company is doing.

nasdaq hearings panel regulatory

"the Company attended a November 11, 2025 hearing and presented its plan of compliance before the Hearings Panel"

A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

HOFFMAN ESTATES, Ill., Dec. 5, 2025 /PRNewswire/ -- Cambium Networks Corporation ("Cambium Networks" or the "Company") (NASDAQ: CMBM), a leading global provider of networking solutions, announced today that on December 3, 2025, the Company received a decision letter ("Decision Letter") from the Nasdaq Hearings Panel (the "Hearings Panel") granting the Company's request for continued listing of the Company's Ordinary Shares on The Nasdaq Global Market, subject to the Company demonstrating compliance with the Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Rule") and the Nasdaq Listing Rule 5250(c)(1) (the "Filing Rule"), and certain other conditions, including the Company demonstrating compliance with the Filing Rule on or before April 16, 2026.

As previously disclosed, the Company received a staff determination letter ("Staff Determination Letter") from the Listing Qualifications Department (the "Staff") of the Nasdaq Stock Market LLC ("Nasdaq") on October 10, 2025 notifying the Company it was not in compliance with the Minimum Bid Price Rule nor the Filing Rule, and these matters served as a basis for delisting the Company's Ordinary Shares from The Nasdaq Global Market. This Staff Determination Letter is in addition to the previously disclosed Staff Determination Letters dated April 16, 2025, May 22, 2025 and August 25, 2025 notifying the Company that it was not in compliance with the Filing Rule. The Company's failure to comply with the Filing Rule relates to the Company's inability to timely file its Annual Report on Form 10-K for the year ended December 31, 2024 and its Quarterly Reports on Form 10-K for the periods ended March 31, 2025 and June 30, 2025. The Company received an additional Staff Determination Letter on November 25, 2025, notifying the Company it was not in compliance with the Filing Rule given the Company's inability to timely file its Quarterly Report on Form 10-Q for the period ended September 30, 2025 (together, with the delinquent filings referenced above, the "Delinquent Filings").

The Company intends to file the Delinquent Filings as per the conditions of the Decision Letter to regain compliance with the Filing Rule.

As previously disclosed, the Company attended a November 11, 2025 hearing and presented its plan of compliance before the Hearings Panel and requested a continued stay of its delisting of its securities on The Nasdaq Global Market pending its return to compliance.

With respect to the Minimum Bid Price Rule, as noted in the Decision Letter, the Company has evidenced a closing bid price of $1.00 or more per share for a minimum of ten (10) consecutive trading sessions as of the date of the Decision Letter. However, pursuant to Nasdaq Rule 5815(c)(4), the Hearings Panel has elected to maintain jurisdiction over the Company until April 8, 2026, the end of its discretion in the Minimum Bid Price Rule matter, and will monitor whether the Company again becomes noncompliant with the Minimum Bid Price Rule. Should the Company become non-compliant with any Nasdaq Listing Rule during this period, it will be required to advise the Hearings Panel of its plan to cure the listing deficiency. The Hearings Panel will, at that time, determine if it is willing to grant the Company an exception to cure the deficiency or simply delist the Company. If the Company maintains compliance with the Minimum Bid Price Rule through April 8, 2026, the Hearings Panel may impose a one-year discretionary Hearings Panel Monitor to ensure the Company maintains compliance.

About Cambium Networks

Cambium Networks enables service providers, enterprises, industrial organizations, and governments to deliver exceptional digital experiences, and device connectivity, with compelling economics. Our ONE Network platform simplifies management of Cambium Networks' wired and wireless broadband and network edge technologies. Our customers can focus more resources on managing their business rather than the network. We make connectivity that just works.

Forward-Looking Statements

This press release contains forward-looking statements, including, but not limited to statements relating to the filing of Delinquent Reports and the Company's ability to regain compliance with the Nasdaq continued listing standards, as well as words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," "seeks," "assumes," "may," "should," "could," "would," and variations of such words and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are based upon the Company's current assumptions, beliefs, and expectations. Forward-looking statements are subject to the occurrence of many events outside of the Company's control. Actual results and the timing of events may differ materially from those contemplated by such forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. These risks and uncertainties include, among other things, the Company's ability to return to and maintain compliance with Nasdaq continued listing standards and whether Nasdaq will grant the Company any relief from delisting. Forward-looking statements should be considered in light of these risks and uncertainties. Investors and others are cautioned not to place undue reliance on forward-looking statements. All forward-looking statements contained herein speak only as of the date hereof. The Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

Contacts: 
Investor Relations
Cambium Networks
investors@cambiumnetworks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cambium-networks-announces-nasdaq-hearings-panel-has-granted-continued-listing-302634079.html

SOURCE Cambium Networks

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Nasdaq decide about Cambium Networks (CMBM) on December 3, 2025?

Nasdaq Hearings Panel granted continued listing subject to compliance conditions and timelines.

What compliance deadlines does CMBM face after the December 3, 2025 Decision Letter?

Cambium must demonstrate Filing Rule compliance by April 16, 2026 and remain compliant with minimum bid rules through April 8, 2026.

Which Nasdaq rules must Cambium Networks (CMBM) satisfy to keep its listing?

Cambium must satisfy Rule 5450(a)(1) (minimum bid price) and Rule 5250(c)(1) (timely SEC filings).

What filings are delinquent for Cambium Networks (CMBM)?

Delinquent filings include the 2024 Form 10-K and Form 10-Qs for Q1, Q2, and Q3 2025.

Could Nasdaq impose additional oversight on CMBM after regaining compliance?

Yes; if Cambium maintains minimum-bid compliance through April 8, 2026, Nasdaq may impose a one-year discretionary monitor.